IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

AMRI awarded development and manufacturing contract by UK government

10:06 AM MDT | September 30, 2013 | Deepti Ramesh

Albany Molecular Research Inc. (AMRI; Albany, NY) says that its wholly owned Albany Molecular Research UK (Holywell, UK) subsidiary has been awarded a seven-year contract for the development and manufacture of an active ingredient under clinical evaluation. The contract was awarded by the Defense Science and Technology Laboratory (Salisbury, UK) acting on behalf of the UK secretary of state for defense, the Department of National Defence of Canada (Ottawa), and minister of defense of the Netherlands. AMRI will initially work on the development and scale-up of the...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa